Filing Flows › Skinvisible (SKVI) › Q1 2025
Skinvisible (SKVI) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 14, 2025
Skinvisible (SKVI) reported revenue of $5K for the first quarter 2025 (Q1 2025), 0% from a year earlier.
Skinvisible, Q1 2025: revenue $5K (0% year over year), net loss $281K, operating cash flow −$32K. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5K | — | 0% |
| Operating profit | −$140K | — | — |
| Net earnings | −$281K | — | — |
| Operating cash flow | −$32K | — | — |
What changed
Revenue was $5K in Q1 2025, roughly flat year over year.
Gross margin was 100.0%, unchanged from a year earlier. Operating costs exceeded revenue by $140K, an operating margin of -2797.0%. Operating expenses grew 13% against flat revenue. The fastest-growing cost line was SG&A (+13%). The quarter ended with a net loss of $281K. Net interest and other expense of $141K was the main reason.
Operating cash flow was −$32K. Non-cash charges added back $5K of depreciation and amortization. Working capital and other items added $244K.
Questions
What was Skinvisible's revenue in the first quarter 2025?
Skinvisible (SKVI) reported revenue of $5K for the first quarter 2025 (Q1 2025), 0% from a year earlier.
Source: Skinvisible 10-Q on SEC EDGAR.